✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Sino Biopharmaceutical Ltd

Common Name
Sino Biopharmaceutical
Country
Hong Kong
Sector
Healthcare
Industry
Biotechnology
Employees
23,056
Ticker
1177
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Sino Biopharmaceutical Ltd. is a diversified biopharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of a wide array of pharmaceuticals. The compan...

Sino Biopharmaceutical's Climate Target Data Preview

As of 2024, Sino Biopharmaceutical has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Sino Biopharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy/Paste is a PRO feature.
a
2025
Limited Data Preview
You are viewing a limited preview of Sino Biopharmaceutical’s Climate Target dataset. The full dataset, available for download, includes detailed baseline information for both absolute and intensity targets, along with reported progress and achievement details as of 2024.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Sino Biopharmaceutical’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sino Biopharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Sino Biopharmaceutical's ESG Report 2024

Insights into Sino Biopharmaceutical's Greenhouse Gas Emissions Pathways

As of 2024, Sino Biopharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a

Does Sino Biopharmaceutical have a target to reduce the emissions from its operations?

As of 2024, Sino Biopharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Sino Biopharmaceutical's most ambitious operational target is to reduce these emissions by 20% by 2025, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue in 2021.a

Sino Biopharmaceutical has already surpassed its operational emissions reduction target, with 2024 levels falling below the 2025 value, achieving its climate goal ahead of schedule.a

Sino Biopharmaceutical's Operational (Scope 1+2) Emissions Pathway

20212024202500000BaselineCurrent (-20%)
Want Full Access to Sino Biopharmaceutical's Climate Targets Dataset?
Start 30-Day Free Trial